首页 | 本学科首页   官方微博 | 高级检索  
     


Fatty liver and lipotoxicity
Authors:Michael Trauner  Marco Arrese  Martin Wagner
Affiliation:1. Laboratory of Experimental and Molecular Hepatology, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 15, 8036 Graz, Austria;2. Department of Gastroenterology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile
Abstract:Fatty liver disease comprises a spectrum ranging from simple steatosis to steatohepatitis which can progress to liver cirrhosis and hepatocellular cancer. Hepatic lipotoxicity may ensue when the hepatic capacity to utilize, store and export fatty acids (FA) as triglycerides is overwhelmed. Additional mechanisms of hepatic lipotoxicity include abnormal FA oxidation with formation of reactive oxygen species, disturbances in cellular membrane FA and phospholipid composition, alterations of cholesterol content and ceramide signalling. Lipotoxicity is a key factor for the progression of fatty liver disease by inducing hepatocellular death, activating Kupffer cells and an inflammatory response, impairing hepatic insulin signalling resulting in insulin resistance, and activation of a fibrogenic response in hepatic stellate cells that can ultimately lead to cirrhosis. Therefore, the concept of hepatic lipotoxicity should be considered in future therapeutic concepts for fatty liver disease.
Keywords:CAR (NR1I3), constitutive androstane receptor   CYP2E1, cytochrome P450 2E1   ER, endoplasmic reticulum   NAFLD, non-alcoholic fatty liver disease   NASH, non-alcoholic steatohepatitis   IR, insulin resistance   FA, fatty acids   PPAR, peroxisome proliferator-activated receptor   ROS, reactive oxygen species   TG, triglyceride   TNF-α, tumor necrosis factor-α   WAT, white adipose tissue
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号